|
|
||||||||
CALL FOR PAPERS
Cardiovascular-Kidney Interactions in Health and Disease
1Neuroscience Program, 2Departments of Pharmacology & Toxicology, 3Department of Physiology, Michigan State University, East Lansing, Michigan
Submitted 11 July 2005 ; accepted in final form 12 September 2005
Dai and colleagues (Dai X, Galligan JJ, Watts SW, Fink GD, and Kreulen DL. Hypertension 43: 10481054, 2004) found that endothelin (ET) stimulated O2 production in sympathetic ganglion neurons in vitro by activating ETB receptors. The objective of the present study was to determine whether activation of ETB receptors in vivo elevates O2 levels in sympathetic ganglia. Because ETB receptor activation increases blood pressure, we also sought to determine whether alteration in O2 levels was a direct effect of ETB receptor activation on sympathetic ganglia or an indirect consequence of hypertension. Male Sprague-Dawley rats received intravenous infusions of either the specific ETB receptor agonist sarafotoxin 6c (S6c; 5 pmol·kg1·min1) or isotonic saline at 0.01 ml/min (control) for 120 min. To measure O2 levels, we removed the inferior mesenteric ganglion immediately after infusion and stained it with dihydroethidine (DHE). Mean arterial pressure increased 26.6 ± 1.7 mmHg in the S6c-treated rats and 3.65 ± 6 mmHg in control rats. Measurements of average pixel intensity revealed that the DHE fluorescence in ganglionic neurons and surrounding glial cells were 96.7% and 160% greater in S6c-treated than in control rats, respectively. To evaluate the effect of elevated blood pressure on O2 production, a separate group of rats received phenylephrine (PE; 10 µg·kg1·min1 iv) for 2 h. MAP increased 31 ± 1.2 mmHg in PE-infused rats. The DHE fluorescence intensity in ganglia of PE-infused rats was significantly greater than that of control rats, 137.7% in neurons and 104.6% in glia but significantly lower than in ganglia from S6c rats. We conclude that ETB receptor activation in vivo significantly enhances O2 levels in sympathetic ganglia, due to both pressor effects and direct stimulation of ETB receptors in ganglion cells.
hypertension; sarafotoxin 6c; sympathetic nervous activity; oxidative stress; reactive oxygen species
This article has been cited by other articles:
![]() |
M. Li, X. Dai, S. Watts, D. Kreulen, and G. Fink Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1546 - R1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Kline, D. J. Kleinhenz, B. Liang, S. Dikalov, D. M. Guidot, C. M. Hart, D. P. Jones, and R. L. Sutliff Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2792 - H2804. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. King, M. Novotny, G. M. Swain, and G. D. Fink Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1262 - R1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cao, X. Dai, L. M. Parker, and D. L. Kreulen Differential Regulation of NADPH Oxidase in Sympathetic and Sensory Ganglia in Deoxycorticosterone Acetate Salt Hypertension Hypertension, October 1, 2007; 50(4): 663 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Chapleau The Continuing Saga of Neuronal Oxidative Stress in Hypertension: Nox, Nox Who's There, and Where? Hypertension, October 1, 2007; 50(4): 600 - 602. [Full Text] [PDF] |
||||
![]() |
G. Fink, M. Li, Y. Lau, J. Osborn, and S. Watts Chronic Activation of Endothelin B Receptors: New Model of Experimental Hypertension Hypertension, September 1, 2007; 50(3): 512 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Pollock and M. P. Schneider Clarifying Endothelin Type B Receptor Function Hypertension, August 1, 2006; 48(2): 211 - 212. [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox Special feature: cardiovascular-kidney interactions in health and disease Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R34 - R36. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |